New volatile anaesthetics in cardiovascular anaesthesia: one step forward, two steps back?

Cardiovascular genetics--two steps forward, one step back.

The recent publication of 2 studies of the genetics of coronary heart disease1,2 provides an opportune moment to reassess strategies and progress towards the time when the genetic investment in this common cause of death and disability will be repaid with better detection and prevention. These 2 studies are important because they are large and their findings appear to be consistent. The genetic...

Two steps forward, one step back.

Participants at a community health information network in Glens Falls, N.Y., have come face-to-face with obstacles that could have meant the end to this rural health network that the New York Department of Health and the John A. Hartford Foundation helped launch more than two years ago. Instead, John Laliberte, Glens Falls Hospital's director of information systems, and the rest of the IS team ...

One step forward, two steps back.

Prior research on child poverty has focused heavily on the roles of family structure and, to a lesser extent, parental work patterns to explain trends over time and differences across groups. However, immigrant child poverty has increased significantly over the past three decades even though labor force participation is high among immigrants and immigrant families are likely to be headed by a m...

One step forward and two steps back.

Mesenchymal stem cell therapy: Two steps forward, one step back.

Mesenchymal stem cell (MSC) therapy is poised to establish a new clinical paradigm; however, recent trials have produced mixed results. Although MSC were originally considered to treat connective tissue defects, preclinical studies revealed potent immunomodulatory properties that prompted the use of MSC to treat numerous inflammatory conditions. Unfortunately, although clinical trials have met ...